These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 19922781)
21. A new near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin A for photodynamic therapy of cancer cells. Jin S; Zhou L; Gu Z; Tian G; Yan L; Ren W; Yin W; Liu X; Zhang X; Hu Z; Zhao Y Nanoscale; 2013 Dec; 5(23):11910-8. PubMed ID: 24129918 [TBL] [Abstract][Full Text] [Related]
22. Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties. Wacker M; Chen K; Preuss A; Possemeyer K; Roeder B; Langer K Int J Pharm; 2010 Jun; 393(1-2):253-62. PubMed ID: 20417701 [TBL] [Abstract][Full Text] [Related]
23. Characterization and photodynamic activity of a new phthalocyanine nanoparticles. Lin R; Zhou L; Fang KL; Lin Y; Wang A; Zhou JH; Wei SH J Mater Sci Mater Med; 2012 Jul; 23(7):1629-35. PubMed ID: 22552828 [TBL] [Abstract][Full Text] [Related]
24. Hypocrellin B-based activatable photosensitizers for specific photodynamic effects against high H Kitamura T; Nakata H; Takahashi D; Toshima K Chem Commun (Camb); 2021 Dec; 58(2):242-245. PubMed ID: 34850796 [TBL] [Abstract][Full Text] [Related]
25. Quantitative and site-directed chemical modification of hypocrellins toward direct drug delivery and effective photodynamic activity. Deng H; Liu X; Xie J; Yin R; Huang N; Gu Y; Zhao J J Med Chem; 2012 Mar; 55(5):1910-9. PubMed ID: 22352922 [TBL] [Abstract][Full Text] [Related]
26. Interactions of CT-DNA with Hypocrellin A and its Al(3+)-Hypocrellin A complex. Ma F; Ge X; Huang H; Yang C; Han L; Zhou J; Yang X Spectrochim Acta A Mol Biomol Spectrosc; 2013 May; 109():158-63. PubMed ID: 23523758 [TBL] [Abstract][Full Text] [Related]
27. Development of copolymeric nanoparticles of hypocrellin B: Enhanced phototoxic effect and ocular distribution. Krishnaswami V; Ponnusamy C; Sankareswaran S; Paulsamy M; Madiyalakan R; Palanichamy R; Kandasamy R; Natesan S Eur J Pharm Sci; 2018 Apr; 116():26-36. PubMed ID: 29055734 [TBL] [Abstract][Full Text] [Related]
28. A novel photosensitizer, 2-butylamino-2-demethoxy-hypocrellin B (2-BA-2-DMHB) - its photodynamic effects on HeLa cells: efficacy and apoptosis. Yang H; Wu T; Zhang M; Zhang Z Biochim Biophys Acta; 2001 Jul; 1540(1):22-31. PubMed ID: 11476891 [TBL] [Abstract][Full Text] [Related]
29. Anion of hypericin is crucial to understanding the photosensitive features of the pigment. Shen L; Ji HF; Zhang HY Bioorg Med Chem Lett; 2006 Mar; 16(5):1414-7. PubMed ID: 16337376 [TBL] [Abstract][Full Text] [Related]
30. Biophysical evaluation of two red-shifted hypocrellin B derivatives as novel PDT agents. Paul BT; Babu MS; Santhoshkumar TR; Karunagaran D; Selvam GS; Brown K; Woo T; Sharma S; Naicker S; Murugesan R J Photochem Photobiol B; 2009 Jan; 94(1):38-44. PubMed ID: 18977666 [TBL] [Abstract][Full Text] [Related]
31. Comparative in vitro study of photodynamic activity of hypericin and hypericinates in MCF-7 cells. de Andrade GP; Manieri TM; Nunes EA; Viana GM; Cerchiaro G; Ribeiro AO J Photochem Photobiol B; 2017 Oct; 175():89-98. PubMed ID: 28865319 [TBL] [Abstract][Full Text] [Related]
32. Antibiotic-free nanotherapeutics: hypericin nanoparticles thereof for improved in vitro and in vivo antimicrobial photodynamic therapy and wound healing. Nafee N; Youssef A; El-Gowelli H; Asem H; Kandil S Int J Pharm; 2013 Sep; 454(1):249-58. PubMed ID: 23834835 [TBL] [Abstract][Full Text] [Related]
33. Photobleaching of hypocrellin B and its butylamino-substituted derivative in solutions. Xu S; Tian C; Chen S; Zhang M; Shen T Photochem Photobiol; 2001 Aug; 74(2):184-90. PubMed ID: 11547552 [TBL] [Abstract][Full Text] [Related]
34. New potential photodynamic therapeutic anti-cancer agents: synthesis and characterization of demethoxy amino-substituted hypocrellins. Wu T; Xu S; Shen J; Song A; Chen S; Zhang M; Shen T Anticancer Drug Des; 2000 Aug; 15(4):287-93. PubMed ID: 11200504 [TBL] [Abstract][Full Text] [Related]
35. Quinones as photosensitizer for photodynamic therapy: ROS generation, mechanism and detection methods. Rajendran M Photodiagnosis Photodyn Ther; 2016 Mar; 13():175-187. PubMed ID: 26241780 [TBL] [Abstract][Full Text] [Related]
36. Ultrasound-Enhanced Self-Exciting Photodynamic Therapy Based on Hypocrellin B. Ding Y; Liu W; Wu J; Zheng X; Ge J; Ren H; Zhang W; Lee CS; Wang P Chem Asian J; 2021 May; 16(10):1221-1224. PubMed ID: 33881805 [TBL] [Abstract][Full Text] [Related]
37. Photosensitizer-loaded dendrimer-modified multi-walled carbon nanotubes for photodynamic therapy. Huang P; Lin J; Yang D; Zhang C; Li Z; Cui D J Control Release; 2011 Nov; 152 Suppl 1():e33-4. PubMed ID: 22195908 [No Abstract] [Full Text] [Related]
38. Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles. Zhao B; Yin JJ; Bilski PJ; Chignell CF; Roberts JE; He YY Toxicol Appl Pharmacol; 2009 Dec; 241(2):163-72. PubMed ID: 19695274 [TBL] [Abstract][Full Text] [Related]
39. Hypocrellin B-encapsulated nanoparticle-mediated rev-caspase-3 gene transfection and photodynamic therapy on tumor cells. Bai D; Xia X; Yow CM; Chu ES; Xu C Eur J Pharmacol; 2011 Jan; 650(2-3):496-500. PubMed ID: 20970418 [TBL] [Abstract][Full Text] [Related]
40. Novel surfactant-like hypocrellin derivatives to achieve simultaneous drug delivery in blood plasma and cell uptake. Zhang Y; Song L; Xie J; Qiu H; Gu Y; Zhao J Photochem Photobiol; 2010; 86(3):667-72. PubMed ID: 20331522 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]